NCC Medical Group is a globally recognized manufacturer specializing in neurodiagnostic and neuro-monitoring technologies. With more than two decades of industry experience, NCC has established itself as a trusted provider of advanced EEG, EMG, PSG, and intraoperative neurophysiological monitoring solutions for healthcare institutions worldwide.
Founded in 1997, NCC has built a comprehensive innovation ecosystem that integrates scientific research, precision manufacturing, and international clinical collaboration. The company's research and development headquarters are located in Shanghai, China, a major global center for medical technology innovation. This R&D hub focuses on advanced neurophysiology research, hardware design, and software algorithm development.
Quality assurance and global compliance operations are coordinated through NCC’s Singapore facility, which serves as the company’s international regulatory and quality management center. This dual-hub operational structure ensures that all NCC products meet strict global medical device standards and regulatory requirements.
NCC is recognized as a National “Little Giant” enterprise under China’s SRDI program. The SRDI designation—Specialized, Refined, Differential, and Innovational—is awarded to companies that demonstrate exceptional technological capability and hold core proprietary patents. This recognition reflects NCC’s commitment to continuous innovation in neurodiagnostic technology.
The company’s product portfolio includes advanced EEG systems, intraoperative neuromonitoring solutions, electromyography devices, and a full range of medical consumables used in neurological diagnostics. These technologies are widely used in neurology departments, sleep laboratories, neurosurgery units, and research institutions.
To support global healthcare providers, NCC has developed a comprehensive international distribution and service network. The company’s neurodiagnostic solutions are currently deployed in more than 50 countries and used in over 5,000 hospitals across China alone. International markets include Southeast Asia, Europe, Australia, the Americas, and Africa.
Beyond manufacturing, NCC places strong emphasis on clinical education and professional training. Through the NCC Innovation Academy and the NeuGuard Service Platform, the company provides continuous technical training programs, workshops, and certification courses for clinicians and biomedical engineers.
NCC currently operates 31 technical training and service centers throughout China, ensuring that hospitals and research institutions receive timely support and technical assistance. This infrastructure enables NCC to deliver rapid response service, equipment maintenance, and clinical consultation when needed.
The company’s mission is to safeguard life and health by advancing safer surgical procedures, improving neurological diagnostics, and supporting high-quality patient care. By combining technological innovation with clinical expertise, NCC continues to develop next-generation neurophysiology systems that support modern medical practice.
Through strategic partnerships with hospitals, universities, and global distributors, NCC Medical Group is committed to expanding access to advanced neurodiagnostic technologies and contributing to the future of neuroscience and healthcare.
Copyright © NCC Medical Co., Ltd. - Privacy policy